CompanyGraph
Kingboard Holdings Limited
0148 · HKEX · Hong Kong
Price data from its KGZ listing on XSTU, quoted in EUR
kingboard.comFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 8 industries, depends on 0
- ScaleMarket cap is $3.68B, above the global median of $1.15B
- FinancialsAltman Z-Score 2.09: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
6.23%Above 5Y avg (4.25%)
Annual Rate
HKD 3.02Paid semi-annual
Payout Ratio
44.3%Sustainable
Payback Period
2.4 yr
Next Ex-Dividend
Dec 11, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
28.86BHKD3.68B · vs all stocks (USD)
Trailing P/E
11.92xvs Conglomerates peers
Revenue (TTM)
52.90BHKD6.74B · vs all stocks (USD)
Profit Margin
8.57%vs Conglomerates peers
Beta
1.18xvs all stocks
52-Week Change
77.87%vs all stocks
Forward Annual Dividend Yield
6.23%vs all stocks
Market Capitalization
28.86BHKD3.68B · vs all stocks (USD)
Enterprise Value
61.75BHKD7.87B · vs all stocks (USD)
Trailing P/E
11.92xvs Conglomerates peers
Forward P/E
5.24xvs Conglomerates peers
Price to Sales (TTM)
1.03xvs Conglomerates peers
Price to Book (MRQ)
0.6710xvs Conglomerates peers
Enterprise to Revenue
1.17xvs Conglomerates peers
Enterprise to EBITDA
6.01xvs Conglomerates peers
Profit Margin
8.57%vs Conglomerates peers
Operating Margin
20.58%vs Conglomerates peers
Return on Assets (TTM)
4.11%vs Conglomerates peers
Return on Equity (TTM)
7.70%vs Conglomerates peers
Revenue (TTM)
52.90BHKD6.74B · vs all stocks (USD)
Revenue per Share (TTM)
47.71HKDUpdated Oct 19, 2026Quarterly Revenue Growth
34.80%vs Conglomerates peers
Gross Profit (TTM)
11.59BHKD1.48B · vs all stocks (USD)
EBITDA (TTM)
6.25BHKD796.18M · vs all stocks (USD)
Net Income (TTM)
4.53BHKD577.39M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
5.00%vs Conglomerates peers
Operating Cash Flow (TTM)
6.61BHKD841.81M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-626.90MHKD-79.88M · vs all stocks (USD)
Forward Annual Dividend Rate
3.02HKDUpdated Oct 19, 2026Forward Annual Dividend Yield
6.23%vs all stocks
Trailing Annual Dividend Rate
2.20HKDUpdated Oct 19, 2026Trailing Annual Dividend Yield
4.54%vs all stocks
5-Year Average Dividend Yield
4.25%vs all stocks
Payout Ratio
44.35%vs Conglomerates peers
Minority Interest (Equity)
5.17BHKDFY2025 · Dec 31, 2025Revenue
45.38BHKDFY2025 · Dec 31, 2025Cost of Goods Sold
37.45BHKDFY2025 · Dec 31, 2025Gross Profit
7.93BHKDFY2025 · Dec 31, 2025Operating Income
4.24BHKD540.72M · vs all stocks (USD)
Pre-tax Income
5.70BHKDFY2025 · Dec 31, 2025Income Tax Expense
597.99MHKDFY2025 · Dec 31, 2025Net Income
5.11BHKDFY2025 · Dec 31, 2025EBIT
6.51BHKDFY2025 · Dec 31, 2025EBITDA (Income Statement)
6.25BHKDFY2025 · Dec 31, 2025Selling, General & Administrative
3.75BHKDFY2025 · Dec 31, 2025Non-operating Interest Income
43.98MHKDFY2025 · Dec 31, 2025Non-operating Interest Expense
802.93MHKDFY2025 · Dec 31, 2025EPS (Basic)
3.97HKDFY2025 · Dec 31, 2025EPS (Diluted)
3.96HKDFY2025 · Dec 31, 2025Basic Shares Outstanding
1.11BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.11BSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
-704.51MHKDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00HKDFY2025 · Dec 31, 2025Operating Cash Flow
4.25BHKDFY2025 · Dec 31, 2025Free Cash Flow
822.53MHKDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
3.47BHKDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
5.70BHKDFY2025 · Dec 31, 2025Other Non-cash Items
758.95MHKDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-2.96BHKDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
749.02MHKDFY2025 · Dec 31, 2025Capital Expenditures
-3.43BHKDFY2025 · Dec 31, 2025Purchase of Investments
-756.92MHKDFY2025 · Dec 31, 2025Sale of Investments
17.14MHKDFY2025 · Dec 31, 2025Net Investing Cash Flow
-4.17BHKDFY2025 · Dec 31, 2025Long-term Debt Issuance
25.10BHKDFY2025 · Dec 31, 2025Long-term Debt Payments
-24.03BHKDFY2025 · Dec 31, 2025Common Dividends Paid
-1.51BHKDFY2025 · Dec 31, 2025Net Financing Cash Flow
-443.84MHKDFY2025 · Dec 31, 2025Shares Outstanding
1.11BSharesUpdated Oct 19, 2026Float Shares
737.78MSharesUpdated Oct 19, 2026% Held by Insiders
33.47%vs all stocks
% Held by Institutions
28.42%vs all stocks
Total Cash (MRQ)
30.19BHKD3.85B · vs all stocks (USD)
Total Cash per Share (MRQ)
27.23HKDUpdated Oct 19, 2026Total Debt (MRQ)
30.87BHKD3.93B · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3533xvs Conglomerates peers
Current Ratio (MRQ)
2.27xvs Conglomerates peers
Book Value per Share (MRQ)
72.10HKDUpdated Oct 19, 2026Total Assets
103.88BHKD13.24B · vs all stocks (USD)
Total Current Assets
42.47BHKDFY2025 · Dec 31, 2025Total Liabilities
34.04BHKDFY2025 · Dec 31, 2025Total Non-current Assets
61.41BHKDFY2025 · Dec 31, 2025Total Non-current Liabilities
11.11BHKDFY2025 · Dec 31, 2025Total Current Liabilities
22.93BHKDFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.47BHKDFY2025 · Dec 31, 2025Other Short-term Investments
8.48BHKDFY2025 · Dec 31, 2025Accounts Receivable
8.76BHKDFY2025 · Dec 31, 2025Inventory
15.12BHKDFY2025 · Dec 31, 2025Accounts Payable
3.63BHKDFY2025 · Dec 31, 2025Short-term Debt
12.11BHKDFY2025 · Dec 31, 2025Long-term Debt
10.69BHKDFY2025 · Dec 31, 2025Common Stock (Book)
110.83MHKDFY2025 · Dec 31, 2025Retained Earnings
53.19BHKDFY2025 · Dec 31, 2025Total Shareholders' Equity
69.84BHKD8.90B · vs all stocks (USD)
52-Week Low
25.10HKDUpdated Oct 19, 202652-Week High
151.80HKDUpdated Oct 19, 202652-Week Change
77.87%vs all stocks
Beta
1.18xvs all stocks
50-Day MA
52.52HKDUpdated Oct 19, 2026200-Day MA
51.55HKDUpdated Oct 19, 2026Avg 10-Day Volume
17.92MSharesUpdated Oct 19, 2026Avg 30-Day Volume
20.03MSharesUpdated Oct 19, 2026Diluted EPS (TTM)
4.06HKDUpdated Oct 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.09: grey zoneSignificant
Altman Z-Score: 2.09
High earnings qualityNotable
Earnings Quality Score: 0.75
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Market cap is $3.68B, above the global median of $1.15BNotable
Market cap (USD): 3,677,397,104.123Global Median: 1,150,342,212.262
Revenue is $6.74B, above the global median of $559.35MNotable
Revenue (USD): 6,740,280,497.275Global Median: 559,350,010.583
Companies that share the same coordination system — how they create, deliver, or capture value.
Anhui Yingliu Electromechanical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Dorman Products Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Heilongjiang Agriculture Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Mitac Holdings Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guizhou Space Appliance Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Drax Group plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Exide Industries Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
SKC Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Beijing Hyperstrong Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Viva Energy Group Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Akebia Therapeutics Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Aeluma Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated